The growing interest in potent weight management has led to considerable exploration into groundbreaking treatments. Currently, Retatrutide, a twin-action hormone and glucagon-like peptide-1 (GLP-1) receptor agonist , has shown promising results in patient trials, suggesting potential for signifi